unknown
Stage
About
FuzionaireDX develops scalable radiotheranostic programs using silicon-based HetSiFA® chemistry to create chemically matched diagnostic PET imaging and radioligand therapies for oncology treatment.
Explore FuzionaireDX's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.